Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Red-Cell Aplasia, Pure

fluorodeoxyglucose f18 has been researched along with Red-Cell Aplasia, Pure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimi, A; Furuichi, K; Hara, A; Hashimoto, A; Hayasaka, N; Iwata, Y; Iyama, S; Kamihara, Y; Kanisawa, Y; Kato, J; Minami, S; Nakajima, C; Okuda, T; Sato, T; Takada, K; Uemura, N; Wada, T1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Red-Cell Aplasia, Pure

ArticleYear
Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.
    International journal of hematology, 2014, Volume: 100, Issue:5

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Histiocytes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Receptors, Erythropoietin; Red-Cell Aplasia, Pure; T-Lymphocytes; Tomography, X-Ray Computed

2014